Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actos (pioglitazone) specified drug-use survey in type 2 diabetes with prior cerebral infarction
jRCT1080222517
- Sponsor
- Takeda
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pioglitazone in type 2 diabetes mellitus (T2DM) and brain infarction, sponsored by Takeda.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)brain infarction
Beyond the preview
Go deeper on jRCT1080222517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222517.